Cancer Science and Oncology

Fatjona Kamberi in 2016 has completed her PhD in Nursing Science from University of Medicine in Tirana Albania and she is currently a Lecturer and the Head of Scientific Research at the Faculty of Public Health University of Vlore Ismail Qemali

Nursing Research Nursing Education Health Education Public Health Women Health Nutrition Cancer Screening

The founder Global Cannabinoid Research Center in Santa Barbara California has extensive history in the world of Cannabis, Hemp, and more. As a patient he's a 3 time Cancer Survivor that's used plant medicine to beat serious health issues. He's the founder of multiple entities in the US Cannabis market and well known for R&D and formulations in the creation of investigative medicine and nutraceuticals. He's an internationally published researcher with a primary focus on minor cannabinoids from Hemp. Robinson is the CEO of a Nanotechnology Food & Beverage corporation that focuses on flavoring and preservation of foods, he's the owner of multiple hemp/cannabis brands and the former Director of Consumer Affairs for the American Academy of Cannabinoid Medicine. His skill set includes extensive legal knowledge coupled with cannabinoid medicine as a former Civil Rights Lobbyist. Prior to that Robinson was a racecar driver and mortgage banker that was critically injured in a high speed auto racing wreck 2.5 decades ago that paralyzed him and caused severe epilepsy in which he uses cannabinoids to treat and recover from.

Cancer, Oncology, Cancer Research

Michael Retsky (PhD in Physics from University of Chicago) made a career change to cancer research thirty years ago. He is on staff at Harvard TH Chan School of Public Health and faculty at University College London. He was on Judah Folkman’s staff at Harvard Medical School for 12 years. Retsky is Editor of a Nature/Springer book on the breast cancer project published July 2017. He was the first person to use what is now called metronomic adjuvant chemotherapy and is a founder and for 10 years was on the Board of Directors of the Colon Cancer Alliance. He has published more than 60 papers in physics and cancer.

Physics and Cancer

Dr. Alexanian Arshak (PhD, VMD) is a founder and Chief Scientific Officer at Cell Reprogramming & Therapeutics LLC. He is also holding an Adjunct Associate Professor position in the Department of Medicine at the Medical College of Wisconsin (MCW). Previously, he held faculty positions in the Departments of Neurosurgery at MCW (2000-2013) and in the Departments of Anatomy and Neurobiology, as well as in Biochemistry and Molecular Biology, at Colorado State University (1997-2000). He has received training at universities and centers world wide, including the Pasteur Institute and University of Montpelier in France, University of Saarland in Germany, Institute of Biochemistry in Armenia, Russia and China.

1) Elucidation of epigenetic mechanism governing normal and cancer cells self-renewal, pluri- and multipotency, lineage commitment, differentiation. 2) Development of new safe and cost-effective cell reprogramming technologies for generation of desired neural subtypes that can be used for the treatment of several neurological disorders including CNS injures, age-related neurological disorders and brain cancers.

Sergey Suchkov was born in the City of Astrakhan, Russia, in a dynasty of medical doctors, graduated from Astrakhan State Medical University and was awarded with MD. Then main-tained his PhD and Doctor’s Degree. And later was working for Helmholtz Eye Research Insti-tute and Moscow Regional Clinical Research Institute (MONIKI). Dr Suchkov was a Secretary-in-Chief of the Editorial Board, Biomedical Science, an international journal published jointly by the USSR Academy of Sciences and the Royal Society of Chemistry, UK. At present, Dr Sergey Suchkov is: (i) a Director, Center for Personalized Medicine, Sechenov University, (ii) Chair, Dept for Translational Medicine, Moscow Engineering Physical University (MAPhI), and (iii) Secretary General, United Cultural Convention (UCC), Cambridge, UK. A Member of the: New York Academy of Sciences, American Chemical Society (ACS), American Heart Association (AHA), AMEE, Dundee, UK; EPMA, Brussels, EU; PMC, Washington, DC, USA and ISPM, Tokyo, Japan.

Cancer Research,Immunology